Vaibhav R. Vaidya

Vaibhav R. Vaidya

Auto-generated profile, based on publicly available information

Vaibhav R. Vaidya

Department of Cardiovascular Diseases Mayo Clinic Rochester Minnesota USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Heart Rhythm
Verified
Journal Article
Closed access
EMElad Maor
Elad Maor
ASAlan Sugrue
Alan Sugrue
CWChance Witt
Chance Witt
VVVaibhav R. Vaidya
Vaibhav R. Vaidya
CDChristopher V. DeSimone
Christopher V. DeSimone
SKSuraj Kapa
Suraj Kapa

11 January 2019 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
VVVaibhav R. Vaidya
Vaibhav R. Vaidya
MDMingyan Dai
Mingyan Dai
SASamuel J. Asirvatham
Samuel J. Asirvatham
RRRobert F. Rea
Robert F. Rea
TTTrena M. Thome
Trena M. Thome
YCYong-Mei Cha
Yong-Mei Cha

1 September 2022 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
FEFatima M. Ezzeddine
Fatima M. Ezzeddine
KSKonstantinos Siontis
Konstantinos Siontis
JGJohn Giudicessi
John Giudicessi
MAMichael J. Ackerman
Michael J. Ackerman
AKAmmar M. Killu
Ammar M. Killu
FMFreddy Del-Carpio Munoz
Freddy Del-Carpio Munoz
Background: Mitral annular disjunction (MAD) has recently been recognized as an arrhythmogenic entity. Data on the electrophysiological substrate as well as the outcomes of catheter ablation of ventricular arrhythmias in patients with MAD is limited. Methods: Forty patients with MAD (mean age 47±15 years; 70% female) underwent catheter ablation for ventricular arrhythmias. Detailed clinical, electrocardiographic, cardiac imaging, and procedural data were collected. Clinical outcomes were compared between patients who had substrate modification in the MAD area and those who did not. Results: Twenty-three (57.5%) patients had ablation for premature ventricular contractions, 10 (25%) patients for sustained ventricular tachycardia, and 7 (17.5%) patients for premature ventricular contraction-triggered ventricular fibrillation. Mean end-systolic MAD length was 10.58±3.49 mm on transthoracic echocardiography. Seventeen (42.5%) patients had preprocedural cardiac magnetic resonance imaging, and 5 (29%) patients had late gadolinium enhancement. Among the 18 (45%) patients who had abnormal local electrograms (low voltage, long-duration, fractionated, isolated mid-diastolic potentials) during electroanatomical mapping, 10 (25%) patients had abnormal electrograms in the anterolateral mitral annulus and/or MAD area. Substrate modification was performed in 10 (25%) patients. Catheter ablation was acutely successful in 36 (90%) patients (elimination of premature ventricular contraction or noninducibility of ventricular tachycardia). After a median follow-up duration of 54.08 (interquartile range, 10.67–89.79) months, premature ventricular contraction burden decreased from a median of 9.75% (interquartile range, 3.25–14) before the ablation to a median of 4% (interquartile range, 1–7.75) after the ablation ( P =0.03 [95% CI, 0.055–6.5]). Eight (20.5%) patients had repeat ablation for ventricular arrhythmias. Substrate modification of the MAD was associated with a trend toward lower rates of repeat ablation (0% versus 26.7%; P =0.16). Conclusions: Patients with MAD have a complex arrhythmogenic substrate, and catheter ablation is effective in reducing recurrence of ventricular arrhythmias. Substrate mapping and ablation may be considered in these patients.

15 April 2019 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
GCGuido Caluori
Guido Caluori
AWAdam Wojtaszczyk
Adam Wojtaszczyk
OYOmar Yasin
Omar Yasin
MPMartin Pesl
Martin Pesl
JWJiří Wolf
Jiří Wolf
ZSZdenek Starek
Zdenek Starek

22 January 2021 in Circulation: Heart Failure
Verified
Journal Article
Closed access
PDF file
CJC. Charles Jain
C. Charles Jain
DPDawn Pedrotty
Dawn Pedrotty
PAPhilip A. Araoz
Philip A. Araoz
ASAlan Sugrue
Alan Sugrue
VVVaibhav R. Vaidya
Vaibhav R. Vaidya
BBBarry A. Borlaug
Barry A. Borlaug
Background: Heart failure with preserved ejection fraction is increasing in prevalence, but few effective treatments are available. Elevated left ventricular (LV) diastolic filling pressures represent a key therapeutic target. Pericardial restraint contributes to elevated LV end-diastolic pressure, and acute studies have shown that pericardiotomy attenuates the rise in LV end-diastolic pressure with volume loading. However, whether these acute effects are sustained chronically remains unknown. Methods: Minimally invasive pericardiotomy was performed percutaneously using a novel device in a porcine model of heart failure with preserved ejection fraction. Hemodynamics were assessed at baseline and following volume loading with pericardium intact, acutely following pericardiotomy, and then again chronically after 4 weeks. Cardiac structure was assessed by magnetic resonance imaging. Results: The increase in LV end-diastolic pressure with volume loading was mitigated by 41% (95% CI, 27%–45%, P <0.0001; ΔLV end-diastolic pressure reduced from +9±3 mm Hg to +5±3 mm Hg, P =0.0003, 95% CI, −2.2 to −5.5). The effect was sustained at 4 weeks (+5±2 mm Hg, P =0.28 versus acute). There was no statistically significant effect of pericardiotomy on ventricular remodeling compared with age-matched controls. None of the animals developed hemodynamic or pathological indicators of pericardial constriction or frank systolic dysfunction. Conclusions: The acute hemodynamic benefits of pericardiotomy are sustained for at least 4 weeks in a swine model of heart failure with preserved ejection fraction, without excessive chamber remodeling, pericarditis, or clinically significant systolic dysfunction. These data support trials evaluating minimally invasive pericardiotomy as a novel treatment for heart failure with preserved ejection fraction in humans.

23 September 2020 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
MZMartin van Zyl
Martin van Zyl
DPDawn M. Pedrotty
Dawn M. Pedrotty
EKErdem Karabulut
Erdem Karabulut
VKVolodymyr Kuzmenko
Volodymyr Kuzmenko
SSSanna Sämfors
Sanna Sämfors
SKSuraj Kapa
Suraj Kapa